24/7 Market News Snapshot 26 November, 2024 – Milestone Scientific, Inc. Common Stock (NYSE:MLSS)

November 26, 2024

DENVER, Colo., 26 November, 2024 (247marketnews.com) – (NYSE:MLSS) are discussed in this article.
Milestone Scientific, Inc. (MLSS), a frontrunner in computerized drug delivery systems, has recently made significant strides in both its stock performance and advancements in medical technology. Following an impressive trading surge of 25.79%, culminating in a stock price of $0.995 from a previous close of $0.791, the company is experiencing heightened investor interest. The current trading volume of 588.14K shares indicates robust market engagement, reflecting a positive sentiment regarding Milestone’s potential.

In parallel to this notable market activity, Milestone Scientific has secured a pivotal contract under the Federal Supply Schedule (FSS) for its innovative CompuFlo® Epidural System. This approval follows the initial registration with the U.S. Government’s System for Award Management (SAM) earlier this year, marking a significant achievement in the company’s growth trajectory. The FSS designation allows Milestone to offer its advanced medical devices at pre-negotiated pricing, streamlining procurement for federal agencies. The contract spans an initial five-year term, with potential extensions extending the total duration up to 20 years, providing an opportunity for sustained accessibility to cutting-edge technology in healthcare.

The CompuFlo® Epidural System employs Milestone’s patented Dynamic Pressure Sensing Technology®, providing real-time feedback to enhance the safety and accuracy of epidural procedures. This innovative approach not only improves patient comfort but also minimizes the risks traditionally associated with such interventions.

Arjan Haverhals, CEO of Milestone Scientific, emphasized the importance of the FSS approval, stating, “This recognition affirms the clinical advantages of our technology and positions us as a vital partner in federal healthcare systems.” As Milestone continues to innovate and grow, it stands poised to redefine standards of care and efficiency in the medical field.

Related news for (MLSS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.